Is Chlamydia an STD? The #1 Reported STI, Explained
Yes — chlamydia is a bacterial STD and America's most nationally reported infection: about 1.6 million cases in 2023. Caused by Chlamydia trachomatis, it spreads through vaginal, anal and oral sex, stays silent in ~70% of women and ~50% of men, and cures completely with a 7-day doxycycline course. Untreated, it's a leading cause of infertility.
The textbook bacterial STD
Chlamydia trachomatis — an obligate intracellular bacterium — transmits through sexual contact with infected fluids/tissue, colonizing the urethra, cervix, rectum, throat and eyes. Its reporting status makes it the #1 nationally notifiable disease in the United States, year after year, ahead of gonorrhea and everything else.
True totals run higher than reported counts — silent infections mean under-detection, which is why prevalence estimates exceed surveillance numbers substantially.
Symptoms (when they bother to appear)
- Women: discharge change, burning urination, bleeding between periods or after sex, pelvic ache — or nothing at all (full sign list).
- Men: urethral burning, penile discharge, testicular heaviness (epididymitis link) — roughly half stay silent too.
- Rectal/throat: usually asymptomatic; discovered only through site-specific swabs.
The silence problem: symptom-free weeks-to-months let infection climb upward in women toward the uterus and tubes. Roughly 10–15% of untreated cervical chlamydia progresses to PID — the scarring condition behind infertility, ectopic pregnancy and chronic pain (PID guide).
Testing and treatment: the good-news chapter
Detection: NAAT urine test or swabs — over 95% sensitive, results in 1–3 days. Annual screening recommended for all sexually active women under 25; risk-based beyond that (schedules here).
Cure: CDC first-line treatment is doxycycline 100mg twice daily for 7 days (azithromycin stepped down after resistance data; amoxicillin remains for pregnancy). Details in the doxycycline guide. Rules that matter:
- No sex until treatment completes + 7 days, both partners treated.
- Retest at 3 months — reinfection rates run high.
- Treated early, no lasting harm; delayed treatment leaves scarring risk on the table.
Related confusions cleared in this page's siblings: fatigue questions, urinary symptoms, and gonorrhea, its partner-in-crime.
Frequently asked questions
Sources & further reading
- 📚 CDC — Chlamydia fact sheet — www.cdc.gov/chlamydia/about
- 📚 CDC — Treatment guidelines: chlamydia — www.cdc.gov/std/treatment-guidelines/chlamydia.htm
- 📚 CDC — Surveillance 2023 — www.cdc.gov/std/statistics